• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性T细胞改善载脂蛋白E基因敲除小鼠中高同型半胱氨酸血症加速的动脉粥样硬化。

Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.

作者信息

Feng Juan, Zhang Zhenmin, Kong Wei, Liu Bo, Xu Qingbo, Wang Xian

机构信息

Department of Physiology and Pathophysiology, School of Basic Medical Science, Peking University, Beijing 100191, PR China.

出版信息

Cardiovasc Res. 2009 Oct 1;84(1):155-63. doi: 10.1093/cvr/cvp182. Epub 2009 Jun 5.

DOI:10.1093/cvr/cvp182
PMID:19502284
Abstract

AIMS

Atherosclerosis is an inflammatory disease with T cell-driven immunoinflammatory responses contributing to disease initiation and progression. We investigated the potential role of regulatory T cells (Tregs) in hyperhomocysteinaemia (HHcy)-accelerated atherosclerosis in apoE-/- mice.

METHODS AND RESULTS

apoE-/- mice were fed normal mouse chow supplemented with or without a high level of homocysteine (Hcy) (1.8 g/L) in drinking water for 2, 4, and 6 weeks. Atherosclerotic lesion area was slightly increased at 2 weeks and substantially elevated at 4 and 6 weeks in HHcy apoE-/- mice. Cotransfer of normal Tregs significantly attenuated atherosclerotic lesion size and infiltration of T cells and macrophages into plaque. Furthermore, Treg cotransfer reversed HHcy-accelerated proliferation of T cells, -increased pro-inflammatory, and -decreased anti-inflammatory cytokine secretion from activated splenic T cells. With a clinically relevant level of plasma Hcy, the proportion of Tregs and suppressive activity in splenic T cells were reduced in HHcy apoE-/- mice, which was associated with reduced mRNA and protein expression of Foxp3, a factor governing mouse Treg development and function. In addition, Hcy significantly attenuated the proportion and suppressive effects of Tregs in vitro.

CONCLUSION

HHcy suppresses the function of Tregs, which may be responsible for HHcy-accelerated atherosclerosis in apoE-/- mice.

摘要

目的

动脉粥样硬化是一种炎症性疾病,T细胞驱动的免疫炎症反应参与疾病的发生和发展。我们研究了调节性T细胞(Tregs)在载脂蛋白E基因敲除(apoE-/-)小鼠高同型半胱氨酸血症(HHcy)加速动脉粥样硬化中的潜在作用。

方法与结果

给apoE-/-小鼠喂食正常小鼠饲料,饮水中添加或不添加高水平同型半胱氨酸(Hcy)(1.8 g/L),持续2、4和6周。HHcy apoE-/-小鼠在2周时动脉粥样硬化病变面积略有增加,在4周和6周时显著升高。共转移正常Tregs可显著减小动脉粥样硬化病变大小,并减少T细胞和巨噬细胞向斑块内的浸润。此外,Treg共转移逆转了HHcy加速的T细胞增殖、增加的促炎细胞因子分泌以及活化脾T细胞抗炎细胞因子分泌的减少。在具有临床相关水平的血浆Hcy时,HHcy apoE-/-小鼠脾T细胞中Tregs的比例和抑制活性降低,这与调节小鼠Treg发育和功能的因子Foxp3的mRNA和蛋白表达降低有关。此外,Hcy在体外显著减弱了Tregs的比例和抑制作用。

结论

HHcy抑制Tregs的功能,这可能是HHcy加速apoE-/-小鼠动脉粥样硬化的原因。

相似文献

1
Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.调节性T细胞改善载脂蛋白E基因敲除小鼠中高同型半胱氨酸血症加速的动脉粥样硬化。
Cardiovasc Res. 2009 Oct 1;84(1):155-63. doi: 10.1093/cvr/cvp182. Epub 2009 Jun 5.
2
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.天然存在的CD4+CD25+调节性T细胞在实验性动脉粥样硬化中的作用。
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):893-900. doi: 10.1161/01.ATV.0000259365.31469.89. Epub 2007 Feb 1.
3
Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.趋化因子CXCL10通过调节效应T细胞和调节性T细胞的局部平衡促进动脉粥样硬化的发生。
Circulation. 2006 May 16;113(19):2301-12. doi: 10.1161/CIRCULATIONAHA.105.605121. Epub 2006 May 8.
4
CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(-/-) mice.CTLA4-IgG 通过抑制 apoE(-/-) 小鼠 T 细胞过度激活来改善同型半胱氨酸加速的动脉粥样硬化。
Cardiovasc Res. 2013 Feb 1;97(2):349-59. doi: 10.1093/cvr/cvs330. Epub 2012 Oct 31.
5
Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.氧化还原因子-1在高同型半胱氨酸血症加速动脉粥样硬化中的作用。
Free Radic Biol Med. 2006 Nov 15;41(10):1566-77. doi: 10.1016/j.freeradbiomed.2006.08.020. Epub 2006 Aug 30.
6
Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.瘦素/瘦素受体信号传导缺陷可改善调节性T细胞免疫反应,并保护小鼠免受动脉粥样硬化的影响。
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2691-8. doi: 10.1161/ATVBAHA.107.149567. Epub 2007 Aug 9.
7
IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.胰岛素样生长因子-1可减轻载脂蛋白E缺陷小鼠的炎症反应,抑制氧化应激,并减缓动脉粥样硬化进程。
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90. doi: 10.1161/ATVBAHA.107.156257. Epub 2007 Oct 4.
8
The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice.载脂蛋白 E 基因敲除小鼠动脉粥样硬化形成过程中的 Th17/Treg 功能失衡。
Cytokine. 2010 Feb;49(2):185-93. doi: 10.1016/j.cyto.2009.09.007. Epub 2009 Oct 27.
9
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.调节性 T 细胞在载脂蛋白 B 肽疫苗介导的抗动脉粥样硬化作用中的作用证据。
J Intern Med. 2011 May;269(5):546-56. doi: 10.1111/j.1365-2796.2010.02311.x. Epub 2010 Nov 29.
10
Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.天然鳞屑突变小鼠中无功能的调节性T细胞及Th2细胞因子产生的缺陷性调控
J Immunol. 2009 Nov 1;183(9):5662-72. doi: 10.4049/jimmunol.0803762. Epub 2009 Oct 7.

引用本文的文献

1
Epigenetic modification of CD4 T cells into Tregs by 5-azacytidine as cellular therapeutic for atherosclerosis treatment.5-氮杂胞苷将 CD4 T 细胞表观遗传修饰为 Tregs 作为动脉粥样硬化治疗的细胞治疗。
Cell Death Dis. 2024 Sep 20;15(9):689. doi: 10.1038/s41419-024-07086-7.
2
An in-depth understanding of the role and mechanisms of T cells in immune organ aging and age-related diseases.深入了解T细胞在免疫器官衰老及与年龄相关疾病中的作用和机制。
Sci China Life Sci. 2025 Feb;68(2):328-353. doi: 10.1007/s11427-024-2695-x. Epub 2024 Sep 2.
3
Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE Mice.
Treg 免疫调节有助于和心方在载脂蛋白 E 小鼠抗动脉粥样硬化的作用。
Chin J Integr Med. 2024 Oct;30(10):896-905. doi: 10.1007/s11655-024-3663-2. Epub 2024 May 16.
4
The role of m5C methyltransferases in cardiovascular diseases.m5C甲基转移酶在心血管疾病中的作用。
Front Cardiovasc Med. 2023 Jul 5;10:1225014. doi: 10.3389/fcvm.2023.1225014. eCollection 2023.
5
Targeting regulatory T cells for cardiovascular diseases.靶向调节性 T 细胞治疗心血管疾病。
Front Immunol. 2023 Feb 23;14:1126761. doi: 10.3389/fimmu.2023.1126761. eCollection 2023.
6
The Impact of Exercise on Immunity, Metabolism, and Atherosclerosis.运动对免疫、代谢和动脉粥样硬化的影响。
Int J Mol Sci. 2023 Feb 8;24(4):3394. doi: 10.3390/ijms24043394.
7
Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiology.调节性 T 细胞在非淋巴组织生理学和病理生理学中的意义。
Front Immunol. 2022 Jul 22;13:954798. doi: 10.3389/fimmu.2022.954798. eCollection 2022.
8
DNA Methyltransferase 3b Accelerates the Process of Atherosclerosis.DNA 甲基转移酶 3b 加速动脉粥样硬化进程。
Oxid Med Cell Longev. 2022 Apr 5;2022:5249367. doi: 10.1155/2022/5249367. eCollection 2022.
9
Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis.调节性T细胞:中医药治疗动脉粥样硬化的新靶点
Chin J Integr Med. 2021 Nov;27(11):867-873. doi: 10.1007/s11655-021-2877-9. Epub 2021 Sep 16.
10
Exosomes and Atherogenesis.外泌体与动脉粥样硬化的发生
Front Cardiovasc Med. 2021 Aug 26;8:738031. doi: 10.3389/fcvm.2021.738031. eCollection 2021.